4-Hydroxynonenal and regulation of cell cycle: Effects on the pRb/E2F pathway

Free Radical Biology and Medicine

Volumn 37, Issue 5, 2004, Pages 597-606

  Barrera, Giuseppina ^a   Pizzimenti, Stefania ^a   Dianzani, Mario U ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

4 Hydroxynonenal; AP 1; cAMP response element binding protein; CBP; CD11b, CD67; cluster of differentiation 11b, 67; CREB; dimethylsulfoxide; DMSO; DP; E2F; Free radicals; HL 60; p300 CREB binding protein; pRb; transcription factor activator protein 1

Indexed keywords

4 HYDROXYNONENAL; ALDEHYDE DERIVATIVE; CYCLIN A; CYCLIN D1; CYCLIN D2; MYC PROTEIN; PROTEIN P21; TRANSCRIPTION FACTOR E2F4;

APOPTOSIS; CELL ACTIVATION; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL STRAIN HL 60; DOWN REGULATION; GENE CONTROL; HUMAN; LEUKEMIA CELL; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; TUMOR; TUMOR CELL; TUMOR GROWTH;

ALDEHYDES; CELL CYCLE; CYCLINS; GROWTH INHIBITORS; HL-60 CELLS; HUMANS; K562 CELLS; RETINOBLASTOMA PROTEIN; TRANSCRIPTION, GENETIC;

EID: 3343002135     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2004.05.023     Document Type: Review

References (88)

1. Dianzani M.U. Lipid peroxidation and cancer. Crit. Rev. Oncol. Hematol. 15:1993;125-147
2. Cheeseman K.H., Collins M., Maddix S.P., Milia A., Proudfoot K., Slater T.F., Burton G.W., Webb A., Ingold K.U. Lipid peroxidation in regenerating rat liver. FEBS Lett. 209:1986;191-196
3. Slater T.F., Cheeseman K.H., Benedetto C., Collins M., Emery S., Maddix S.P., Nodes J.T., Proudfoot K., Burton G.W., Ingold K.U. Studies on the hyperplasia ('regeneration') of the rat liver following partial hepatectomy: changes in lipid peroxidation and general biochemical aspects. Biochem. J. 265:1990;51-59
4. Rossi M.A., Cecchini G. Lipid peroxidation in hepatomas of different degrees of deviation. Cell Biochem. Funct. 1:1983;49-54
5. Dianzani M.U. 4-hydroxynonenal from pathology to physiology. Mol. Aspects Med. 24:2003;263-272
6. Tessitore L., Bonelli G., Costelli P., Matera L., Pileri A., Baccino F.M., Dianzani M.U. Effect of two aliphatic aldehydes, methylglyoxal and 4-hydroxypentenal, on the growth of Yoshida ascites hepatoma AH-130. Chem. Biol. Interact. 70:1989;227-240
7. Barrera G., Martinetti S., Fazio V., Mannari V., Paradisi L., Parola M., Frati L., Dianzani M.U. Effect of 4-hydroxynonenal on c-myc expression. Toxicol. Pathol. 15:1987;238-240
8. Fazio V.M., Barrera G., Martinotti S., Farace M.G., Giglioni B., Frati L., Manzari V., Dianzani M.D. 4-Hydroxynonenal, a product of cellular lipid peroxidation, which modulates c-myc and globin gene expression in K562 erythroleukemic cells. Cancer Res. 52:1992;4866-4871
9. Cheng J.Z., Singhal S.S., Saini M., Singhal J., Piper J.T., Van Kuijk F.J., Zimniak P., Awasthi Y.C., Awasthi S. Effects of mGST A4 transfection on 4-hydroxynonenal-mediated apoptosis and differentiation of K562 human erythroleukemia cells. Arch. Biochem. Biophys. 372:1999;29-36
10. Barrera G., Biasi F., Fazio V.M., Paradisi L., Dianzani M.U. Repeated treatments with a low HNE concentration affect K562 cell proliferation. Columbano A., et al. Chemical Carcinogenesis. 1991;337-342 Plenum, New York
11. Barrera G., Muraca R., Pizzimenti S., Serra A., Rosso C., Saglio G., Farace M.G., Fazio V.M., Dianzani M.U. Inhibition of c-myc expression induced by 4-hydroxynonenal, a product of lipid peroxidation, in theHL-60 human leukemic cell line. Biochem. Biophys. Res. Commun. 203:1994;553-561
12. Barrera G., Di Mauro C., Muraca R., Ferrero D., Cavalli G., Fazio V.M., Paradisi L., Dianzani M.U. Induction of differentiation in human HL-60 cells by 4-hydroxynonenal, a product of lipid peroxidation. Exp. Cell Res. 197:1991;148-152
13. Breitman T.R., Hemmi H., Imaizumi M. Induction by physiological agents of differentiation of the human leukemia cell line HL-60 to cells with functional characteristics. Prog. Clin. Biol. Res. 226:1986;215-233
14. Barrera G., Pizzimenti S., Serra A., Ferretti C., Fazio V.M., Saglio G., Dianzani M.U. 4-Hydroxynonenal specifically inhibits c-myb but does not affect c-fos expressions in HL-60 cells. Biochem. Biophys. Res. Commun. 227:1996;589-593
15. Rinaldi M., Barrera G., Spinanti P., Pizzimenti S., Ciafrè S.A., Parella P., Farace M.G., Signori E., Dianzani M.U., Fazio V.M. Growth inhibition and differentiation induction in murine erythroleukemia cells by 4-hydroxynonenal. Free Radic. Res. 34:2001;629-637
16. Calonghi N., Boga C., Cappadone C., Pagnotta E., Bertucci C., Fiori J., Masotti L. Cytotoxic and cytostatic effects induces by 4-hydroxynonenal in human osteosarcoma cells Biochem. Biophys. Res. Commun. 292:2002;1502-1507
17. Barrera G., Pizzimenti S., Muraca R., Barbiero G., Bonelli G., Baccino F.M., Fazio V.M., Dianzani M.U. Effect of 4-hydroxynonenal on cell cycle progression and expression of differentiation associated antigens in HL-60 cells. Free Radic. Biol. Med. 20:1996;455-462
18. Sherr C.J. Cancer cell cycles. Science. 274:1996;1672-1677
19. Murray A.W. Recycling the cell cycle: cyclins revisited. Cell. 116:2004;221-234
20. Pizzimenti S., Barrera G., Dianzani M.U., Brüsselbach S. Inhibition of D1, D2, and A-cyclin expression in HL-60 cells by the lipid peroxidation product 4-hydroxynonenal. Free Radic. Biol. Med. 26:1999;1578-1586
21. Sherr C.J., Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1995;1149-1163
22. Hirama T., Koeffler H.P. Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood. 86:1995;841-854
23. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 366:1993;701-704
24. INK4D) in human acute myeloid leukaemia and normal myeloid cells. Leukemia. 11:1997;54-63
25. Hunter T., Pines J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell. 79:1994;573-582
26. Jiang H., Lin J., Su Z., Collart F.R., Huberman E., Fischer P.B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21 WAF1/CIP1 expression in absence of p53. Oncogene. 9:1994;3397-3406
27. Zhang W., Grasso L., McClain G.D., Gambel A.M., Cha Y., Travali S., Deisserot A.B., Mercer W.E. p-53 independent induction of WAF1/CIP1 in human leukaemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res. 55:1995;668-674
28. Barrera G., Pizzimenti S., Laurora S., Moroni E., Giglioni B., Dianzani M.U. 4-Hydroxynonenal affects pRb/E2F pathway in HL-60 human leukemic cells. Biochem. Biophys. Res. Commun. 285:2002;267-275
29. Bartek J., Bartkova J., Lukas J. The retinoblastoma protein pathway and the restriction point. Curr. Opin. Cell Biol. 8:1996;805-814
30. Chellappan S.P., Hiebert S., Mudryj M., Horowitz J.M., Nevins J.R. The E2F transcription factor is a cellular target for the RB protein. Cell. 65:1991;1053-1061
31. Harbour J.W., Dean D.C. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 14:2000;2393-2409
32. Ikeda M., Laszlo J., Nevins J.R. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. USA. 93:1996;3215-3220
33. Thalmeier K., Synovzik H., Mertz R., Winnacker E.L., Lipp M. Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human myc promoter. Genes Dev. 3:1992;527-536
34. Morishita R., Gibbons G.H., Horiuchi M., Ellison K.E., Nakajima M., Zhang L., Kaneda Y., Ogihara T., Dzau V.J. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc. Natl. Acad. Sci. USA. 92:1995;5855-5859
35. Oswald F., Lovec H., Moroy T., Lipp M. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions. Oncogene. 9:1994;2029-2036
36. Stevens C., La Thangue N.B. E2F and cell cycle control: a double-edged sword. Arch. Biochem. Biophys. 412:2003;157-169
37. Nevins J.R. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science. 258:1992;424-429
38. Hiyama H., Iavarone A., Reeves S.A. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F. Oncogene. 16:1998;1513-1523
39. Yang X.H., Sladek T.L. Overexpression of the E2F-1 transcription factor gene mediates cell transformation. Gene Expr. 4:1995;195-204
40. Singh P., Wong S.H., Hong W. Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation. EMBO J. 13:1994;3329-3338
41. Weintraub S.J., Prater C.A., Dean D.C. Retinoblastoma protein switches the E2F site from positive to negative element. Nature. 358:1992;259-261
42. Alesse E., Zazzeroni F., Angelucci A., Giannini G., Di Marcotullio L., Gulino A. The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphospholylation and E2F sequestering. Cell Death Differ. 5:1998;381-389
43. Paramio J.M., Segrelles C., Casanova M.L., Jorcano J.L. Opposite functions for E2F1 and E2F4 in human epidermal keratinocyte differentiation. J. Biol. Chem. 275:2000;41219-41226
44. Wang Q.M., Feinman R., Kashanchi F., Houghton J.M., Studzinski G.P., Harrison L.E. Changes in E2F binding after phenylbutyrate-induced differentiation of caco-2 colon cancer cells. Clin. Cancer Res. 6:2000;2951-2958
45. Albert T., Wells J., Funk J.O., Pullner A., Raschke E.E., Stelzer G., Meisterernst M., Farnham P.J., Eick D. The chromatin structure of the dual c-myc promoter P1/P2 is regulated by separate elements. J Biol. Chem. 276:2001;20482-20490
46. O'Connor R.J., Schaley J.E., Feeney G., Hearing P. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters. Oncogene. 20:2001;1882-1891
47. Pearson A., Greenblatt J. Modular organization of the E2F1 activation domain and its interaction with general transcription factors TBP and TFIIH. Oncogene. 15:1997;2643-2658
48. Fry C.J., Pearson A., Malinowski E., Bartley S.M., Greenblatt J., Farnham P.J. Activation of the murine dihydrofolate reductase promoter by E2F1: a requirement for CBP recruitment. J Biol. Chem. 274:1999;15883-15891
49. Ferreira R., Magnaghi-Jaulin L., Robin P., Harel-Bellan A., Trouche D. The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase. Proc. Natl. Acad. Sci. USA. 95:1998;10493-10498
50. Ishida S., Shudo K., Takada S., Koike K. A direct role of transcription factor E2F in c-myc gene expression during granulocytic and macrophage-like differentiation of HL-60 cells. Cell Growth Differ. 6:1995;229-237
51. Barrera G., Pizzimenti S., Serra A., Fazio V.M., Canuto R.A., Dianzani M.U. Effect of bioactive aldehydes on cell proliferation and c-myc expression in HL-60 human leukemic cells. Cancer Detection Prev. 24:2000;244-251
52. Sharma R., Sharma A., Yang Y., Awasthi S., Yang Y., Singhal S.S., Zimniak P., Awasthi Y.C. Functional reconstitution of Ral-binding GTPase activating protein, RLIP76, in proteoliposomes catalyzing ATP-dependent transport of glutathione conjugate of 4-hydroxynonenal. Acta Biochim Pol. 49:2002;693-701
53. Awasthi Y.C., Sharma R., Cheng J.Z., Yang Y., Sharma A., Singhal S.S., Awasthi S. Role of 4-hydroxynonenal in stress-mediated apoptosis signaling. Mol. Aspects Med. 24:2003;219-230
54. Sharma R., Brown D., Awasthi S., Yang Y., Sharma A., Patrick B., Saini M.K., Singh S.P., Zimniak P., Singh S.V., Awasthi Y.C. Transfection with 4-hydroxynonenal-metabolizing glutathione s-transferase isozymes leads to phenotypic transformation and immortalization of adherent cells. Eur. J. Biochem. 271:2004;1690-1701
55. Uchida K., Shiraishi M., Naito Y., Torii Y., Nakamura Y., Osawa T. Activation of stress signaling pathways by the end product of lipid peroxidation: 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J. Biol. Chem. 274:1999;2234-2242
56. Camandola S., Poli G., Mattson M.P. The lipid peroxidation product 4-hydroxy-2,3-nonenal increases AP-1-binding activity through caspase activation in neurons. J. Neurochem. 74:2000;159-168
57. Cheng J.Z., Singhal S.S., Sharma A., Saini M., Yang Y., Awasthi S., Zimniak P., Awasthi Y.C. Transfection of mGSTA4 in HL-60 cells protects against 4-hydroxynonenal-induced apoptosis by inhibiting JNK-mediated signaling. Arch. Biochem. Biophys. 392:2001;197-207
58. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E.R., Mizuno Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl. Acad. Sci. USA. 93:1996;2696-2701
59. Uchida K., Szweda L.I., Chae H.Z., Stadtman E.R. Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proc. Natl. Acad. Sci. USA. 90:1993;8742-8746
60. Chung F.L., Nath R.G., Ocando J., Nishikawa A., Zhang L. Deoxyguanosine adducts of t-4-hydroxy-2-nonenal are endogenous DNA lesions in rodents and humans: detection and potential sources. Cancer Res. 60:2000;1507-1511
61. Hu W., Feng Z., Eveleigh J., Iyer G., Pan J., Amin S., Chung F.L., Tang M.S. The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma. Carcinogenesis. 23:2002;1781-1789
62. Guichardant M., Taibi-Tronche P., Fay L.B., Lagarde M. Covalent modifications of aminophospholipids by 4-hydroxynonenal. Free Radic Biol. Med. 25:1998;1049-1056
63. Barrera G., Brossa O., Fano V.M., Farace M.G., Paradisi L., Gravela E., Dianzani M.U. Effects of 4-hydroxynonenal, a product of lipid peroxidation, on cell proliferation and ornithine decarboxylase activity. Free Radic. Res. Commun. 14:1991;81-89
64. Robino G., Parola M., Marra F., CaIigiuri A., De Franco R.M.S., Zamara E., Bellomo G., Gentilini P., Pinzani M., Dianzani M.D. Interaction between 4-hydroxy-2,3-alkenals and the platelet-derived growth factor beta receptor: reduced tyrosine phosphorylation and down-stream signaling in hepatic stellate cells. J. BioI. Chem. 275:2000;40461-40567
65. Paradisi L., Panagini C., Parola M., Barrera G., Dianzani M.D. Effects of 4-hydroxynonenal in adenylate cyclase and 5′-nucleotidase activities in rat liver plasma membranes. Chem. Biol. lnteract. 53:1985;209-217
66. Rossi M.A., Garramone A., Dianzani M.U. Stimulation of 4-hydroxy-2,3-trans-nonenal, a lipid peroxidation production hepatic phospholipase C. J. Tissue React. 10:1988;323-325
67. Rossi M.A., Fidale F., Di Mauro C., Esterbauer H., Dianzani M.U. Effect of 4-hydroxy-2,3-trans-nonenal and related aldehydes on phospholipase C activity of rat neutrophils. Int. J. Tissue React. 15:1993;201-205
68. Barrera G., Pizzimenti S., Muzio G., Maggiora M., Garriamone A., Biasi F., Dianzani M.U., Canuto R.A. Enzymatic pattern of aldehyde metabolism during HL-60 cell differentiation. Biochem. Biophys. Res. Commun. 223:1996;73-79
69. Parola M., Robino G., Marra F., Pinzani M., BelIomo G., Leonarduzzi G., Chiarugi P., Camandola S., Poli G., Waeg G., Gentilini P., Dianzani M.U. HNE interacts directly with JNK isoforms in human hepatic stellate cells. J. Clin. Invest. 102:1998;1942-1950
70. Chiarpotto E., Domenicotti C., Paola D., Vitali A., Nitti M., Pronzato M.A., Biasi F., Cottalasso D., Marinari D.M., Dragonetti A., Cesaro P., Isidoro C., Poli G. Regulation of rat hepatocyte protein kinase C beta isoenzymes by the lipid peroxidation product 4-hydroxy-2,3-nonenal: a signaling pathway to modulate vesicular transport of glycoproteins. Hepatology. 29:1999;1565-1572
71. Rinaldi M., Barrera G., Aquino A., Spinsanti P., Pizzimenti S., Farace M.G., Dianzani M.U., Fazio V.M. 4-Hydroxynonenal-induced MEL cell differentiation involves PKC activity translocation. Biochem. Biophys. Res. Commun. 172:2000;75-80
72. Nitti M., Domenicotti C., D'Abramo C., Assereto S., Cottalasso D., Melloni E., Poli G., Biasi F., Marinari U.M., Pronzato M.A. Activation of PKC-β isoforms mediates HNE-induced MCP-1 release by macrophages. Biochem. Biophys. Res. Commun. 294:2002;547-552
73. Curzio M., Esterbauer H., Dianzani M.U. Chemotactic activity of hydroxyalkenals on rat neutrophils. Int. J. Tissue React. 7:1985;137-142
74. Di Mauro C., Cavalli G., Amprimo M.C., Paradisi L., Scano G., Curzio M., Dianzani M.U. Influence of 4-hydroxynonenal on chemiluminescence production by unstimulated and opsonized zymosan-stimulated human neutrophils. Cell Biochem. Funct. 8:1990;147-155
75. Dianzani C., Parrini M., Ferrara C., Fantozzi R. Effect of 4-hydroxynonenal on superoxide anion production from primed human neutrophils. Cell Biochem. Funct. 14:1996;193-200
76. Camandola S., Scavazza A., Leonarduzzi G., Biasi F., Chiarpotto E., Azzi A., Poli G. Biogenic 4-hydroxynonenal activates transcription factor AP-l but not NF-kB in cells of the macrophage lineage. BioFactors. 6:1997;173-179
77. Tricarico M., Rinaldi M., Bonmassar E., Fuggetta M.P., Barrera G., Fazio V.M. Effect of 4-hydroxynonenal, a product of lipid peroxidation, on natural cell mediated cytotoxicity. Anticancer Res. 19:1999;5149-5154
78. Maggiora M., Dianzani M.U., Rossi M.A. Effect of 4-hydroxynonenal, a lipid peroxidation product, on exocytosis in HL-60 cells. Cell Biochem. Funct. 20:2002;303-307
79. Parola M., Pinzani M., Casini A., Albano E., Poli G., Gentilini A., Gentilini P., Dianzani M.U. Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha (I) gene expression and synthesis in human liver fat-storing cells. Biochem. Biophys. Res. Commun. 194:1993;1044-1050
80. Basu-Modak S., Luscher P., Tyrrell R.M. Lipid metabolite involvement in the activation of the human heme oxygenase-1 gene. Free Radic. Biol. Med. 20:1996;887-897
81. Leonarduzzi G., Scavazza A., Biasi F., Chiarpotto E., Camandola S., Vogel S., Dargel R., Poli G. The lipid peroxidation end product 4-hydroxy-2,3-nonenal upregulates transforming growth factor beta l expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis. FASEB J. 11:1997;851-857
82. Marra F., DeFranco R., Grappone C., Parola M., Milani S., Leonarduzzi G., Pastacaldi S., Wenzel D.O., Pinzani M., Dianzani M.U., Laffi G., Gentilini P. Expression of monocyte chemotactic protein-l precedcs monocyte recruitment in a far model of acute liver injury, and is modulated by vitamin E. J. Invest. Med. 47:1999;66-75
83. Tamagno E., Bardini P., Obbili A., Vitali A., Borghi R., Zaccheo D., Pronzato M., Danni O., Smith M., Perry G., Tabaton M. Oxidative stress increases expression and activity of BACE in NT(2) neurons. Neurobiol. Dis. 10:2002;279-288
84. Zamara E., Novo E., Marra F., Gentilini A., Romanelli R.G., Caligiuri A., Robino G., Tamagno E., Aragno M., Danni O., Autelli R., Colombatto S., Dianzani M.U., Pinzani M., Parola M. 4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells. J. Hepatol. 40:2004;60-68
85. Zarkovic N., Ilic Z., Jurin M., Scaur R.J., Puhl H., Esterbauer H. Stimulation of HeLa cell growth by physiological concentrations of 4-hydroxynonenal. Cell Biochem. Funct. 1:1993;279-286
86. Ruef J., Rao G.N., Li F., Bode C., Patterson C., Bhatnagar A., Runge M.S. Induction of rat aortic smooth muscle cell growth by the lipid peroxidation product 4-hydroxy-2-nonenal. Circulation. 97:1998;1071-1078
87. Cambiaggi C., Dominici S., Comporti M., Pompella A. Modulation of human T-lymphocyte proliferation by 4-hydroxynonenal, the bioactive product of neutrophil-dependent lipid peroxidation. Life Sci. 61:1997;777-785
88. Pizzimenti S., Laurora S., Briatore F., Ferretti C., Dianzani M.U., Barrera G. Synergistic effect of 4-hydroxynonenal and PPAR ligands in controlling human leukemic cell growth and differentiation. Free Radic. Biol. Med. 32:2002;233-245